Enliven Therapeutics (ELVN) Shares Outstanding (Entity) (2019 - 2026)
Enliven Therapeutics (ELVN) posted Shares Outstanding (Entity) of 73.25 million for Q2 2026, up 23.7% from 59.23 million a year earlier and up 20.3% from the prior quarter.
Powered by 
Analysis
Enliven Therapeutics (ELVN) Shares Outstanding (Entity) (2019 - 2026) Analysis & Trends
For FY2025, Enliven Therapeutics' Shares Outstanding (Entity) came in at 59.44 million, up 21.5% from FY2024.
- Annual Shares Outstanding (Entity) has increased for five consecutive years, with a five-year compound annual growth rate of 76.4% (FY2020 to FY2025).
- In prior years, Enliven Therapeutics' Shares Outstanding (Entity) was 48.94 million in FY2024 (+18.5%), 41.29 million in FY2023 (+528.3%), 6.57 million in FY2022 (+21.4%) and 5.42 million in FY2021 (+55.6%).
- The Q2 2026 figure stands as the highest quarterly Shares Outstanding (Entity) in data going back to Q1 2019.
- On a year-over-year basis, Shares Outstanding (Entity) has increased in each of the last 15 quarters, with growth averaging 19.8% over the last eight quarters.
- Across the past five years, year-over-year growth in Shares Outstanding (Entity) ran from 0.0% in Q3 2022 to 528.3% in Q4 2023.
- According to Business Quant data, Shares Outstanding (Entity) for the three prior quarters was 60.89 million (Q1 2026), 59.44 million (Q4 2025) and 59.26 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Enliven Therapeutics | 3.36 Bn | 3.36 Bn | - | 73.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 73.25 Mn |
| Mar 31, 2026 | 60.89 Mn |
| Dec 31, 2025 | 59.44 Mn |
| Sep 30, 2025 | 59.26 Mn |
| Jun 30, 2025 | 59.23 Mn |
| Mar 31, 2025 | 49.04 Mn |
| Dec 31, 2024 | 48.94 Mn |
| Sep 30, 2024 | 47.25 Mn |
| Jun 30, 2024 | 47.17 Mn |
| Mar 31, 2024 | 46.78 Mn |
| Dec 31, 2023 | 41.29 Mn |
| Sep 30, 2023 | 41.20 Mn |
| Jun 30, 2023 | 41.15 Mn |
| Mar 31, 2023 | 18.51 Mn |
| Dec 31, 2022 | 6.57 Mn |
| Sep 30, 2022 | 6.57 Mn |
| Jun 30, 2022 | 6.57 Mn |
| Mar 31, 2022 | 6.57 Mn |
| Dec 31, 2021 | 5.42 Mn |
| Sep 30, 2021 | 6.57 Mn |
API Access
Enliven Therapeutics Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=ELVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "ELVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=ELVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();